WellO2 Overview
- Founded
-
2014
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Later Stage VC
- Investors
-
3
WellO2 General Information
Description
Developer of respiration therapy devices designed to soothe the airflow and strengthen respiratory health and muscles. The company's therapy device combines adjustable breathing resistance and warm vapor inhalation to clear mucus, mitigate irritation in airways and strengthen lungs, enabling asthma and other patients to get relief from acute or chronic breathing difficulties and heal shallow breathing or snoring.
Contact Information
Website
www.wello2.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
- Verstaankatu 5 a 3
- 33100 Tampere
- Finland
+358 040 0000000
WellO2 Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 00.000 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 11-Sep-2018 | 00.000 | 00.000 | 00.00 | Completed | Generating Revenue |
| 2. Early Stage VC | 02-Dec-2015 | $163K | $958K | 00.000 | Completed | Startup |
| 1. Seed Round | 07-Jan-2014 | $796K | $796K | 00.000 | Completed | Startup |
WellO2 Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | ||
| Ordinary | 0,000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | ||
| Ordinary | 1,000 | $175.05 | $175.05 | 0x | $175.05 | 3.36% | ||
| Ordinary | 10,606 | $44 | $44 | 0x | $44 | 35.64% |
WellO2 Patents
WellO2 Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2020081883-A | Device for care of respiratory wellbeing and for training and improvement of respiratory function | Pending | 19-Nov-2018 | 000000000 | 0 |
| EP-3653252-B1 | A device for the care of respiratory wellbeing and for training and the improvement of respiratory function | Active | 19-Nov-2018 | 00000000000 | |
| EP-3653252-A1 | A device for the care of respiratory wellbeing and for training and the improvement of respiratory function | Active | 19-Nov-2018 | 000000000 | |
| AU-2013314362-A1 | A device for the care of respiratory diseases and for the improvement of pulmonary function | Active | 13-Sep-2012 | 000000000 | |
| AU-2013314362-B2 | A device for the care of respiratory diseases and for the improvement of pulmonary function | Active | 13-Sep-2012 | A61M16/16 |
WellO2 Executive Team (5)
WellO2 Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Aulis Kärkkäinen | WellO2 | Founder & Chairman | 000 0000 |
| Jussi Holopainen | Self | Board Member | 000 0000 |
WellO2 Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
WellO2 Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Extentum | Other | Minority | 000 0000 | 000000 0 | |
| Finnvera | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Takoa Invest | PE/Buyout | Minority | 000 0000 | 000000 0 |